Back to HALO
Virtus Investment Advisers, LLC → HALO
Virtus Investment Advisers, LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$2.7M
Q3 2026
Peak value
$2.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $598K |
| Q4 2025 | $739K |
| Q1 2026 | $877K |
| Q2 2026 | $1.3M |
| Q3 2026 | $2.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.7M | 24.3K | — | — |
| Q2 2026 | $1.3M | 16.7K | — | — |
| Q1 2026 | $877K | 13.6K | — | — |
| Q4 2025 | $739K | 11.0K | — | — |
| Q3 2025 | $598K | 8.1K | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M